BioSpace News Archive

Cannabis for medical purposes is garnering acceptance globally, here are some companies to keep an eye on as the market grows.

Medical Marijuana, Inc. announced today that its subsidiary Kannaway®, the first direct selling company to offer cannabidiol (CBD) hemp botanical products, has attracted new leadership to its Brand Ambassador base.

Aldoxorubicin Being Studied in NantCell Clinical Trials in Combination with Immune-Based Therapy for the Treatment of Squamous Cell Carcinoma, Metastatic Pancreatic and Triple Negative Breast Cancers

Membership loyalty program offers enhanced benefits and value as well as access to on-demand pharmacy care

MS On My Mind is part of the company’s #MSInsideOut global campaign, aimed at providing a deeper understanding of MS around the world

Dovetail increases global footprint with seven new distributors

Don Panter joins S&W to lead multi-crop focus in Americas

The Summit will host the year’s largest gathering of the Utah life sciences industry, featuring world-class speakers, education sessions and valuable networking opportunities

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera® (atomoxetine) Capsules in the United States market approved by the U.S. Food and Drug Administration (USFDA).

Anticipates projected pro forma annual net revenue of between $80 and $90 million.